Insulin :: New insulin pen with digital memory simplifies diabetes management
Diabetes management can be overwhelming, and data shows less than half of the 15 million being treated for diabetes have blood sugar levels within the recommended range.
Treatment
Herpes :: Herpes treatment could slow HIV progression
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the New England Journal of Medicine.
Anemia :: Roche suspends enrollment for anemia drug trial
Roche announced that it is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy.
HIV :: Safety Alert – Baraclude, entecavir tablets and oral solution
Healthcare professionals are advised that when considering therapy with Baraclude in an HIV/HBV co-infected patient not receiving HAART, the risk of developing HIV resistance cannot be excluded based on current information.
HIV :: UN rep expelled after comment on Gambian president’s AIDS cure
The government of The Gambia gave the most senior United Nations official in the country 48 hours to leave the country starting Friday, following remarks she made criticising Gambian President Yahya Jammeh?s widely-publicised cure for HIV/AIDS.
Eye :: 2007 ARVO annual meeting draws spotlight on aging eye
Age-related eye diseases, their treatment, and the latest research to find cures will take center stage at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held at the Greater Fort Lauderdale/Broward County Convention Center in Fort Lauderdale, Fla., May 6-10, 2007.
ADHD :: ADHD drugmakers to expand health warnings
US FDA directs ADHD drugmakers to notify patients about cardiovascular adverse events and psychiatric adverse events from the use of ADHD drugs.
Heart :: MUSC helps turn heart guidelines into lifelines
The Medical University of South Carolina, (MUSC) was recognized for participating in an American Heart Association and American Stroke Association program called Get With the Guidelines.
HIV :: New AIDS drugs aim to fight resistant HIV
Gilead Sciences, Inc. (Nasdaq:GILD) announced the completion of a Phase II clinical trial of GS 9137, a novel oral HIV integrase inhibitor.
Asthma :: Significant asthma control and improved lung function with Symbicort
Data show significant asthma control and improved lung function with Symbicort.